肝细胞生长因子与心血管疾病研究进展
Progress in the study of hepatocy growth factor and cardiovascular disease
出处
《河南医学研究》
CAS
2005年第2期182-184,共3页
Henan Medical Research
参考文献16
-
1Matsumoto K, Morishita R, Moriguchi A, et al. Inhibition of neointima by angiotensin-converting enzyme inhibitor in porcine coronary artery balloon-injury model[J]. Hypertension, 2001,37(4) :270.
-
2Hayashi K, Nakamura S, Morishita R, et al. In vivo transfer of human hepatocyte growth factor gene accelerates re-endothelialization and inhibits neointimal formation after balloon injury in rat model[J]. Gene Ther,2000,7(9): 1664-1671.
-
3Iwatsubo H, Nagano M, Sakai T, et al. Converting enzyme inhibitor improves forearm reactive hyperemia in essential hypertension[J]. Hypertension, 1997,29(2) :286-290.
-
4Haug C, Schmid-Kotsas A, Zorn U, et al. Hepatocyte growth factor is upregulated by low-density lipoproteins and inhibits endothelin-1 release [J] . Heart and circulatory physiology,2000,279( 11 ) :2865-2871.
-
5Morishita R. Recent progress in gene therapy for cardiovascular disease [J]. Cicr, 2002,66(9) :1077-1086.
-
6Iwata K, Sawa Y, Sakakids S, et al. A role of hepatocyte growth factorin the mechanism of cardica hypertrophy: a novel gene therapy with HGF for hypertyophied heart[J]. Circulation,2000,102 ( 18 suppl Ⅱ ): Ⅱ -28.
-
7Taniyama Y, Morishita R, Aoki M, et al. Angiogensis and anti-fibrotic action by hepatocyte growth factor in cardiomyopathic hamsters[ J]. Circulation, 2000,102(2) :246-252.
-
8Heeschen C, Dimmeler S, Hamm CW, et al. Prognostic significance of angiogenic growth factor serum levels in patients with acute coronary syndromes[ J ]. Circulation, 2003,107 (8): 524-530.
-
9TaniyamaY, Morishita R, Aoki M, et al. Therapeutic angiogenesis. Induced by human hepatocyte growth factor gene in rat and rabbit hind limb ischemia modeis: preclinical study for treatment of peripheral arterial disease[J] .Gene Ther, 2001,8(1): 181-189.
-
10Morishita R, Sakaki M, Yamamoto K, et al. Impairment of collateral formation in Lp transgenic mice: therapeutic angiogenesis induced by human hepatocyte growth factor gene [J]. Circulation, 2001, 105 (10): 1491-1496.
-
1李瑞湘,洪涛.细胞自噬与2型糖尿病患者并发肿瘤的关系[J].广东医学,2016,37(3):462-464. 被引量：8
-
2钱瑾邺,王邦宁.HGF在高血压和肾素—血管紧张素系统中的研究进展[J].山东医药,2008,48(1):139-140. 被引量：3
-
3李俊青,孙建宁,李军祥.环氧化酶-2及相关信号通路在慢性萎缩性胃炎中的研究进展[J].中国中西医结合消化杂志,2013,21(8):437-441. 被引量：9
-
4齐永芬,夏春芳,陈亚红,薛琳,庞永正,唐朝枢.肾上腺髓质素对尾加压素Ⅱ刺激的血管平滑肌细胞增殖的影响[J].中国病理生理杂志,2002,18(3):230-232. 被引量：12
-
5马维勇.支气管哮喘与干扰素[J].医学理论与实践,2001,14(3):216-218. 被引量：1
-
6巨卫平,朱振红.胃溃疡患者治疗前后血TNF,EGF水平的观察[J].放射免疫学杂志,2002,15(1):35-36. 被引量：10
-
7马维勇.支气管哮喘中的干扰素研究进展[J].临床肺科杂志,2001,6(3):39-41.
-
8潘频华.气道平滑肌增生的影响因素及信号转导机制[J].国外医学（生理病理科学与临床分册）,1999,19(1):41-44.
-
9焦明丽（综述）,苌新明（审校）.高血糖与肝纤维化形成机制的研究[J].中华腹部疾病杂志,2006,6(5):386-388. 被引量：2
-
10周文红,胡国龄.γ-干扰素治疗肝纤维化近况[J].中西医结合肝病杂志,2001,11(4):249-251. 被引量：2
